Skip to main content
SpringerLink
Log in

EBNA1 Contributions to EBV-Associated Tumours

  • Chapter
  • First Online:
EBNA1 and Epstein-Barr Virus Associated Tumours

Part of the book series: SpringerBriefs in Cancer Research ((BRIEFSCANCER,volume 3))

  • 609 Accesses

Abstract

B cells are the main site of EBV latency and EBV latent infection involves the immortalisation of resting B lymphocytes. Therefore, it is not surprising that most of the tumours associated with EBV infection are B cell lymphomas. Several different types of EBV-associated B cell lymphomas are known, each with distinct profiles of latent gene expression.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Altmann, M., Pich, D., Ruiss, R., Wang, J., Sugden, B., & Hammerschmidt, W. (2006). Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV’s transforming genes. Proceedings of the National Academy of Sciences of the United States of America, 103, 14188–14193

    Article  PubMed  CAS  Google Scholar 

  • Bornkamm, G. W. (2009). Epstein-Barr virus and its role in the pathogenesis of Burkitt’s lymphoma: an unresolved issue. Seminars in Cancer Biology, 19, 351–365

    Article  PubMed  CAS  Google Scholar 

  • Cao, J. Y., Mansouri, S., & Frappier, L. (2011). Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein-Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses. Journal of Virology, 85(19), 10425–10430

    Google Scholar 

  • Chen, J. N., He, D., Tang, F., & Shao, C. K. (2012). Epstein-Barr virus-associated gastric carcinoma: a newly defined entity. Journal of Clinical Gastroenterology, 46, 262–271

    Article  PubMed  CAS  Google Scholar 

  • Cheng, T. C., Hsieh, S. S., Hsu, W. L., Chen, Y. F., Ho, H. H., & Sheu, L. F. (2010). Expression of Epstein-Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity. International Journal of Oncology, 36, 151–160

    PubMed  CAS  Google Scholar 

  • Deacon, E. M., Pallesen, G., Niedobitek, G., Crocker, J., Brooks, L., Rickinson, A. B., et al. (1993). Epstein-Barr virus and Hodgkin’s disease: transcriptional analysis of virus latency in the malignant cells. Journal of Experimental Medicine, 177, 339–349

    Article  PubMed  CAS  Google Scholar 

  • Drotar, M. E., Silva, S., Barone, E., Campbell, D., Tsimbouri, P., Jurvansu, J., et al. (2003). Epstein-Barr virus nuclear antigen-1 and Myc cooperate in lymphomagenesis. International Journal of Cancer, 106, 388–395

    Article  CAS  Google Scholar 

  • Fukayama, M. (2010). Epstein-Barr virus and gastric carcinoma. Pathology International, 60, 337–350

    Article  PubMed  CAS  Google Scholar 

  • Hong, M., Murai, Y., Kutsuna, T., Takahashi, H., Nomoto, K., Cheng, C. M., et al. (2006). Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt’s lymphoma cells. Journal of Cancer Research and Clinical Oncology, 132, 1–8

    Article  PubMed  CAS  Google Scholar 

  • Hume, S., Reisbach, G., Feederle, R., Delecluse, H.-J., Bousset, K., Hammerschmidt, W., et al. (2003). The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. Proceedings of the National Academy of Sciences, 100, 10989–10994

    Article  Google Scholar 

  • Hummel, M., Anagnostopoulos, I., Dallenbach, F., Korbjuhn, P., Dimmler, C., & Stein, H. (1992). EBV infection patterns in Hodgkin’s disease and normal lymphoid tissue: expression and cellular localization of EBV gene products. British Journal of Haematology, 82, 689–694

    Article  PubMed  CAS  Google Scholar 

  • Kang, M. S., Hung, S. C., & Kieff, E. (2001). Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth. Proceedings of the National Academy of Sciences of the United States of America, 98, 15233–15238

    Article  PubMed  CAS  Google Scholar 

  • Kang, M. S., Lu, H., Yasui, T., Sharpe, A., Warren, H., Cahir-McFarland, E., et al. (2005). Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice. Proceedings of the National Academy of Sciences of the United States of America, 102, 820–825

    Article  PubMed  CAS  Google Scholar 

  • Kang, M. S., Soni, V., Bronson, R., & Kieff, E. (2008). Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in c57bl/6 j mice. Journal of Virology, 82, 4180–4183

    Article  PubMed  CAS  Google Scholar 

  • Kaul, R., Murakami, M., Choudhuri, T., & Robertson, E. S. (2007). Epstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model. Journal of Virology, 81, 10352–10361

    Article  PubMed  CAS  Google Scholar 

  • Kennedy, G., Komano, J., & Sugden, B. (2003). Epstein-Barr virus provide a survival factor to Burkitt’s lymphomas. Proceedings of the National Academy of Sciences, 100, 14269–14274

    Article  CAS  Google Scholar 

  • Kube, D., Vockerodt, M., Weber, O., Hell, K., Wolf, J., Haier, B., et al. (1999). Expression of Epstein-Barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the hodgkin cell line L428. Journal of Virology, 73, 1630–1636

    PubMed  CAS  Google Scholar 

  • Murakami, M., Lan, K., Subramanian, C., & Robertson, E. S. (2005). Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration. Journal of Virology, 79, 1559–1568

    Article  PubMed  CAS  Google Scholar 

  • O’Neil, J. D., Owen, T. J., Wood, V. H., Date, K. L., Valentine, R., Chukwuma, M. B., et al. (2008). Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. Journal of General Virology, 89, 2833–2842

    Article  PubMed  Google Scholar 

  • Raab-Traub, N. (2002). Epstein-Barr virus in the pathogenesis of NPC. Seminars in Cancer Biology, 12, 431–441

    Article  PubMed  CAS  Google Scholar 

  • Shannon-Lowe, C., Adland, E., Bell, A. I., Delecluse, H. J., Rickinson, A. B., & Rowe, M. (2009). Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. Journal of Virology, 83, 7749–7760

    Article  PubMed  CAS  Google Scholar 

  • Sheu, L. F., Chen, A., Meng, C. L., Ho, K. C., Lee, W. H., Leu, F. J., et al. (1996). Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo. Journal of Pathology, 180, 243–248

    Article  PubMed  CAS  Google Scholar 

  • Sivachandran, N., Sarkari, F., & Frappier, L. (2008). Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathogens, 4, e1000170

    Article  PubMed  Google Scholar 

  • Sivachandran, N., Thawe, N. N., & Frappier, L. (2011). Epstein-Barr virus nuclear antigen 1 replication and segregation functions in nasopharyngeal carcinoma cell lines. Journal of Virology, 85, 10425–10430

    Article  PubMed  CAS  Google Scholar 

  • Sivachandran, N., Dawson, C. W., Young, L. S., Liu, F. F., Middeldorp, J., & Frappier, L. (2012). Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma. Journal of Virology, 86, 60–68.

    Google Scholar 

  • Tao, Q., & Chan, A. T. (2007). Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Reviews in Molecular Medicine, 9, 1–24

    Article  PubMed  Google Scholar 

  • Thorley-Lawson, D. A., & Gross, A. (2004). Persistence of the Epstein-Barr virus and the origins of associated lymphomas. New England Journal of Medicine, 350, 1328–1337

    Article  PubMed  CAS  Google Scholar 

  • Tsao, S. W., Tsang, C. M., Pang, P. S., Zhang, G., Chen, H., & Lo, K. W. (2012). The biology of EBV infection in human epithelial cells. Seminars in Cancer Biology, 22, 137–143

    Article  PubMed  CAS  Google Scholar 

  • Tsimbouri, P., Drotar, M. E., Coy, J. L., & Wilson, J. B. (2002). Bcl-xL and RAG genes are induced and the response to IL-2 enhanced in EmuEBNA-1 transgenic mouse lymphocytes. Oncogene, 21, 5182–5187

    Article  PubMed  CAS  Google Scholar 

  • Wilson, J. B., Bell, J. L., & Levine, A. J. (1996). Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO Journal, 15, 3117–3126

    PubMed  CAS  Google Scholar 

  • Yasuda, A., Noguchi, K., Minoshima, M., Kashiwazaki, G., Kanda, T., Katayama, K., et al. (2011). DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization. Cancer Science, 102, 2221–2230

    Article  PubMed  CAS  Google Scholar 

  • Yin, Q., & Flemington, E. K. (2006). siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cells. Virology, 346, 385–393

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Toronto, Kings College Circle 1, Toronto, ON, M5S 1A8, Canada

    Lori Frappier

Authors
  1. Lori Frappier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lori Frappier .

Rights and permissions

Reprints and permissions

Copyright information

© 2013 The Author(s)

About this chapter

Cite this chapter

Frappier, L. (2013). EBNA1 Contributions to EBV-Associated Tumours. In: EBNA1 and Epstein-Barr Virus Associated Tumours. SpringerBriefs in Cancer Research, vol 3. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6886-8_4

Download citation

Publish with us

Policies and ethics

Search

Navigation